会议材料

IDWeek2024 - 感染性疾病周 2024
IDWeek 2024
-
美国 · 洛杉矶

本内容仅供您个人及教育用途。请勿下载或进一步传播。未经版权所有者许可,不得进一步复制或传播

共4条结果
会议壁报
Comparison of COVID-19 Inpatient Burden in Hospitalized Children Age < 5 Years, by SARS-CoV-2 Variant
Andersen KM, Porter TM, Reimbaeva M, McColgan M, Lopez SMC
IDWeek2024 - 感染性疾病周 2024 | 感染性疾病 | COVID-19 | 病毒感染
会议壁报
Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario, Canada
Kassee C, Kyaw MH, Zhong Z, Shigayeva A, Martin C, Farooqi L, Coleman B, Gold W, Kandel C, Major M, Mubareka S, Valluri S, Mclaughlin JM, McGeer A
IDWeek2024 - 感染性疾病周 2024 | 感染性疾病 | COVID-19 | 病毒感染
口头报告
Efficacy of Nirmatrelvir-Ritonavir in High-Risk Trial Participants with Prior SARS-CoV-2 Infection or Vaccination: A Pooled Analysis
Mclaughlin JM, Leister-Tebbe H, Bao W, Quercia R, Hammond J
IDWeek2024 - 感染性疾病周 2024 | 感染性疾病 | COVID-19 | 病毒感染
会议壁报
Patient Reported Outcomes of Nirmatrelvir/Ritonavir Treatment for High-risk, Non-Hospitalized Adults with Symptomatic COVID-19
Cha-Silva AS, Coetzer H, Gebo K, Ren J, Scott A, Cappelleri JC, Ansari W, Leister-Tebbe H
IDWeek2024 - 感染性疾病周 2024 | 感染性疾病 | COVID-19 | 病毒感染